This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nazerian, K Articles by Ogawa, R Search for Related Content PubMed PubMed Citation Articles by Nazerian, K Articles by Ogawa, R

Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.

Avian Disease and Oncology Laboratory, U.S. Department of Agriculture, East Lansing, Michigan 48823.

ABSTRACT

Fowlpox virus (FPV) recombinants expressing the glycoprotein B and the phosphorylated protein (pp38) of the GA strain of Marek's disease virus (MDV) were assayed for their ability to protect chickens against challenge with virulent MDV. The recombinant FPV expressing the glycoprotein B gene elicited neutralizing antibodies against MDV, significantly reduced the level of cell-associated viremia, and, similar to the conventional herpesvirus of turkeys, protected chickens against challenge with the GA strain and the highly virulent RB1B and Md5 strains of MDV. The recombinant FPV expressing the pp38 gene failed to either elicit neutralizing antibodies against MDV or protect the vaccinated chickens against challenge with MDV.

This article has been cited by other articles:

• Tischer, B. K., Schumacher, D., Beer, M., Beyer, J., Teifke, J. P., Osterrieder, K., Wink, K., Zelnik, V., Fehler, F., Osterrieder, N. (2002). A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. J. Gen. Virol. 83: 2367-2376 [Abstract] [Full Text]  
• Yoshida, S., Fujisawa, A., Tsuzaki, Y., Saitoh, S. (2000). Identification and Expression of a Mycoplasma gallisepticum Surface Antigen Recognized by a Monoclonal Antibody Capable of Inhibiting Both Growth and Metabolism. Infect. Immun. 68: 3186-3192 [Abstract] [Full Text]  
• Sonoda, K., Sakaguchi, M., Okamura, H., Yokogawa, K., Tokunaga, E., Tokiyoshi, S., Kawaguchi, Y., Hirai, K. (2000). Development of an Effective Polyvalent Vaccine against both Marek's and Newcastle Diseases Based on Recombinant Marek's Disease Virus Type 1 in Commercial Chickens with Maternal Antibodies. J. Virol. 74: 3217-3226 [Abstract] [Full Text]